[1]李莎莎,胡义德.改良PF方案诱导化疗局部晚期鼻咽癌的临床观察[J].陆军军医大学学报(原第三军医大学学报),2011,33(04):414-417.
 Li Shasha,Hu Yide.Induction chemotherapy efficacy and toxicity of nedaplatin combined tegafur for locally advanced nasopharyngeal carcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(04):414-417.
点击复制

改良PF方案诱导化疗局部晚期鼻咽癌的临床观察(/HTML )
分享到:

陆军军医大学学报(原第三军医大学学报)[ISSN:1000-5404/CN:51-1095/R]

卷:
33卷
期数:
2011年第04期
页码:
414-417
栏目:
论著
出版日期:
2011-02-28

文章信息/Info

Title:
Induction chemotherapy efficacy and toxicity of nedaplatin combined tegafur for locally advanced nasopharyngeal carcinoma
作者:
李莎莎胡义德
第三军医大学新桥医院全军肿瘤研究所
Author(s):
Li Shasha Hu Yide
Cancer Research Center, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China
关键词:
鼻咽癌化学治疗奈达铂替加氟
Keywords:
nasopharyngeal carcinoma chemotherapy nedaplatin tegafur
分类号:
R730.53;R739.63;R979.1
文献标志码:
A
摘要:
目的   观察奈达铂(nedaplatin,NDP)和替加氟(tegafur,FT-207)联合化疗方案在局部晚期鼻咽癌诱导化疗中的近期疗效和毒副反应。   方法   采用回顾性分析方法,收集我科60例初治的局部晚期鼻咽癌病例,归为改良PF方案组和常规PF方案组,每组30例,分别接受NDP+FT-207方案(NDP 30 mg/m2,d1~3;FT-207 600 mg/m2,d1~5;CF 0.2 g,d1~5,每3周1次)和常规DDP+5-FU方案(DDP 30 mg/m2,d1~3;5-FU 500 mg/m2,d1~5;CF 0.2 g,d1~5,每3周1次)诱导化疗,2周期化疗结束后行鼻咽部及颈部淋巴结常规放疗,观察各组的疗效和毒副反应,并进行统计学分析。   结果   改良PF方案组完全缓解率(complete remission rate, CR)为83.3%,部分缓解率(partial remission rate, PR)为13.3%;常规PF方案组CR率为70%,PR率为30%,两组比较差异无统计学意义(P>0.05)。改良PF方案组Ⅲ-Ⅳ度粒细胞减少发生率为6.6%,常规PF方案组为3.3%,两组比较差异无统计学意义(P>0.05)。改良PF方案组Ⅲ-Ⅳ度恶心、呕吐发生率为6.7%,而常规PF方案组为26.7%,两组比较差异有统计学意义(P<0.05)。   结论   奈达铂联合替加氟治疗局部晚期鼻咽癌有较好疗效,毒副反应较轻,值得在鼻咽癌诱导化疗中推广运用。
Abstract:
Objective   To evaluate the efficacy and toxicity of induction chemotherapy involving nedaplatin (NDP) and tegafur (FT-207) in treatment of locally advanced nasopharyngeal carcinoma(NPC).   Methods   Sixty patients, who were newly diagnosed and pathologically proven as NPC at III and IVa stages and admitted in our department from May 2003 to July 2010, were assigned to 2 groups (n=30). All patient characteristics of the 2 groups were well balanced. They underwent an induction chemotherapy with NDP combined with FT-207 (NDP 30 mg/m2, d1-3;FT-207 600 mg/m2, d1-5; CF 0.2 g,d1-5) or DDP combined with 5-FU(DDP 30 mg/m2,d1-3;5-FU 500 mg/m2,d1-5;CF 0.2 g,d1-5) for 21 d as one cycle respectively for 2 cycles. The clinical efficacy and toxicity were evaluated after the induction chemotherapy and radiotherapy. Meanwhile the comparative study was made between the 2 groups.   Results   All of cases were eligible for clinical response evaluation. Similar clinical complete response rate and partial response rate  were observed between the 2 groups (83.3% vs 70.0%, and 13.3% vs 30.0% respectively, P>0.05). There was no significant difference in incidence of grade III and IV toxicity including granulocytopenia in the observer group and the control group (6.6% vs 3.3%, P>0.05). However significant difference was found in incidence of vomiting  between the 2 groups(6.7% vs 26.7%, P<0.05).   Conclusion   Our study indicates that induction chemotherapy with nedaplatin and tegafur is a safe and effective regimen for patients with locally advanced nasopharyngeal carcinoma.

相似文献/References:

[1]李彩霞,王凤英,李玉艳,等.小鼠卵巢早衰动物模型的构建[J].陆军军医大学学报(原第三军医大学学报),2008,30(06):506.
 LI Cai-xia,WANG Feng-ying,LI Yu-yan,et al.Establishment of mouse model of premature ovarian failure[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(04):506.
[2]杨小民,罗荣城,马红京,等.5-氨基乙酰丙酸光动力杀伤人鼻咽癌耐药/非耐药细胞株的实验研究[J].陆军军医大学学报(原第三军医大学学报),2007,29(11):1046.
 YANG Xiao-min,LUO Rong-cheng,MA Hong-jing,et al.Effect of 5-aminolevulinic acid mediated photodynamic therapy on human nasopharyngeal carcinoma cell line CNE2 and CNE2/DDP in vitro[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(04):1046.
[3]颜芳,傅强.替吉奥胶囊联合多西他赛治疗铂类失败晚期胃癌的临床观察[J].陆军军医大学学报(原第三军医大学学报),2011,33(15):1581.
[4]徐江宁,刘明明.鼻咽部鳞状细胞癌侵犯眼眶及表现为眶尖综合征1例[J].陆军军医大学学报(原第三军医大学学报),2009,31(12):1235.
[5]陈丽,刘求真,邱际华,等.人Snail基因RNAi慢病毒载体对鼻咽癌5-8F细胞增殖和侵袭的影响[J].陆军军医大学学报(原第三军医大学学报),2009,31(12):1151.
 CHEN Li,LIU Qiu-zhen,QIU Ji-hua,et al.Lentiviral vector for RNA interference of human Snail gene inhibits proliferation and invasion of nasopharyngeal carcinoma 5-8F cell line[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(04):1151.
[6]何建明,黄海辉,梁后杰.鼻咽癌伴副肿瘤综合征1例[J].陆军军医大学学报(原第三军医大学学报),2009,31(06):554.
[7]邱际华,刘求真,陈丽,等.CXCR4/SDF-1对鼻咽癌细胞增殖与迁移能力的影响[J].陆军军医大学学报(原第三军医大学学报),2009,31(07):598.
 QIU Ji-hua,LIU Qiu-zhen,CHEN Li,et al.Effect of CXCR4/SDF-1 on proliferation and migration of human nasopharyngeal carcinoma cell lines[J].J Amry Med Univ (J Third Mil Med Univ),2009,31(04):598.
[8]赵萍萍,邹容,屈元姣,等.Ang-1和Ang-2及其受体Tie-2在鼻咽癌患者血循环中的表达及临床意义[J].陆军军医大学学报(原第三军医大学学报),2012,34(13):1289.
 Zhao Pingping,Zou Rong,Qu Yuanjiao,et al.Serum levels of ang-1, ang-2 and their receptor Tie-2 in nasopharyngeal carcinoma[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(04):1289.
[9]邓恋,刘陶文,屈元姣,等.淋巴管侵犯与鼻咽癌患者淋巴结转移的关系[J].陆军军医大学学报(原第三军医大学学报),2013,35(13):1424.
[10]石宇良,曾泉,龙表利,等.PCDH8基因表达对鼻咽癌细胞生物学效应的影响[J].陆军军医大学学报(原第三军医大学学报),2013,35(14):1455.
 Shi Yuliang,Zeng Quan,Long Biaoli,et al.Biological effects of PCDH8 expression in nasopharyngeal carcinoma cells[J].J Amry Med Univ (J Third Mil Med Univ),2013,35(04):1455.
[11]蒋金妍,边志衡,谢颖,等.PF和PF+新福菌素联合放疗对中晚期鼻咽癌的近期疗效对比[J].陆军军医大学学报(原第三军医大学学报),2004,26(24):0.[doi:10.16016/j.1000-5404.2004.24.015 ]
 JIANG Jin-yan,BIAN Zhi-heng,XIE Yin,et al.[J].J Amry Med Univ (J Third Mil Med Univ),2004,26(04):0.[doi:10.16016/j.1000-5404.2004.24.015 ]

更新日期/Last Update: 2011-02-19